SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Chambers TJ 2000 Regulation of the differentiation and function of osteoclasts. J Pathol 192: 413.
  • 2
    Everts V, Aronson DC, Beertsen W 1985 Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis. Calcif Tissue Int 37: 2531.
  • 3
    Everts V, Beertsen W, Schroder R 1988 Effects of the proteinase inhibitors leupeptin and E-64 on osteoclastic bone resorption. Calcif Tissue Int 43: 172178.
  • 4
    Bromme D, Okamoto K, Wang BB, Biroc S 1996 Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem 271: 21262132.
  • 5
    Bromme D, Okamoto K 1995 Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. Biol Chem Hoppe Seyler 376: 379384.
  • 6
    Gelb BD, Shi GP, Chapman HA, Desnick RJ 1996 Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273: 12361238.
  • 7
    Johnson MR, Polymeropoulos MH, Vos HL, Ortiz de Luna RI, Francomano CA 1996 A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis. Genome Res 6: 10501055.
  • 8
    Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K 1998 Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95: 1345313458.
  • 9
    Gowen M, Lazner F, Dodds R, Kapadia R, Feild J, Tavaria M, Bertoncello I, Drake F, Zavarselk S, Tellis I, Hertzog P, Debouck C, Kola I 1999 Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14: 16541663.
  • 10
    Bromme D, Klaus JL, Okamoto K, Rasnick D, Palmer JT 1996 Peptidyl vinyl sulphones: A new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L. Biochem J 315: 8589.
  • 11
    Falgueyret JP, Oballa RM, Okamoto O, Wesolowski G, Aubin Y, Rydzewski RM, Prasit P, Riendeau D, Rodan SB, Percival MD 2001 Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L. J Med Chem 44: 94104.
  • 12
    Lark MW, Stroup GB, James IE, Dodds RA, Hwang SM, Blake SM, Lechowska BA, Hoffman SJ, Smith BR, Kapadia R, Liang X, Erhard K, Ru Y, Dong X, Marquis RW, Veber D, Gowen M 2002 A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat. Bone 30: 746753.
  • 13
    Stroup GB, Lark MW, Veber DF, Bhattacharyya A, Blake S, Dare LC, Erhard KF, Hoffman SJ, James IE, Marquis RW, Ru Y, Vasko-Moser JA, Smith BR, Tomaszek T, Gowen M 2001 Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate. J Bone Miner Res 16: 17391746.
  • 14
    Inui T, Ishibashi O, Inaoka T, Origane Y, Kumegawa M, Kokubo T, Yamamura T 1997 Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J Biol Chem 272: 81098112.
  • 15
    Brage M, Abrahamson M, Lindstrom V, Grubb A, Lerner UH 2005 Different cysteine proteinases involved in bone resorption and osteoclast formation. Calcif Tissue Int 76: 439447.
  • 16
    Delaisse JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L 2003 Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 61: 504513.
  • 17
    Hill PA, Murphy G, Docherty AJ, Hembry RM, Millican TA, Reynolds JJ, Meikle MC 1994 The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci 107: 30553064.
  • 18
    Everts V, Delaisse JM, Korper W, Beertsen W 1998 Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J Bone Miner Res 13: 14201430.
  • 19
    Everts V, Delaisse JM, Korper W, Niehof A, Vaes G, Beertsen W 1992 Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol 150: 221231.
  • 20
    Everts V, Korper W, Docherty AJ, Beertsen W 1999 Matrix metalloproteinase inhibitors block osteoclastic resorption of calvarial bone but not the resorption of long bone. Ann N Y Acad Sci 878: 603606.
  • 21
    Shorey S, Heersche JN, Manolson MF 2004 The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula. Bone 35: 909917.
  • 22
    Everts V, Korper W, Jansen DC, Steinfort J, Lammerse I, Heera S, Docherty AJ, Beertsen W 1999 Functional heterogeneity of osteoclasts: Matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J 13: 12191230.
  • 23
    Hill PA, Buttle DJ, Jones SJ, Boyde A, Murata M, Reynolds JJ, Meikle MC 1994 Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem 56: 118130.
  • 24
    Goto T, Kiyoshima T, Moroi R, Tsukuba T, Nishimura Y, Himeno M, Yamamoto K, Tanaka T 1994 Localization of cathepsins B, D, and L in the rat osteoclast by immuno-light and -electron microscopy. Histochemistry 101: 3340.
  • 25
    Goto T, Tsukuba T, Kiyoshima T, Nishimura Y, Kato K, Yamamoto K, Tanaka T 1993 Immunohistochemical localization of cathepsins B, D and L in the rat osteoclast. Histochemistry 99: 411414.
  • 26
    Goto T, Yamaza T, Tanaka T 2003 Cathepsins in the osteoclast. J Electron Microsc (Tokyo) 52: 551558.
  • 27
    Kakegawa H, Nikawa T, Tagami K, Kamioka H, Sumitani K, Kawata T, Drobnic-Kosorok M, Lenarcic B, Turk V, Katunuma N 1993 Participation of cathepsin L on bone resorption. FEBS Lett 321: 247250.
  • 28
    Rifkin BR, Vernillo AT, Kleckner AP, Auszmann JM, Rosenberg LR, Zimmerman M 1991 Cathepsin B and L activities in isolated osteoclasts. Biochem Biophys Res Commun 179: 6369.
  • 29
    Moroi R, Yamaza T, Nishiura T, Nishimura Y, Terada Y, Abe K, Himeno M, Tanaka T 1997 Immunocytochemical study of cathepsin L and rat salivary cystatin-3 in rat osteoclasts treated with E-64 in vivo. Arch Oral Biol 42: 305315.
  • 30
    Debari K, Sasaki T, Udagawa N, Rifkin BR 1995 An ultrastructural evaluation of the effects of cysteine-proteinase inhibitors on osteoclastic resorptive functions. Calcif Tissue Int 56: 566570.
  • 31
    Xia L, Kilb J, Wex H, Li Z, Lipyansky A, Breuil V, Stein L, Palmer JT, Dempster DW, Bromme D 1999 Localization of rat cathepsin K in osteoclasts and resorption pits: Inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones. Biol Chem 380: 679687.
  • 32
    Wieczerzak E, Drabik P, Lankiewicz L, Oldziej S, Grzonka Z, Abrahamson M, Grubb A, Bromme D 2002 Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases. J Med Chem 45: 42024211.
  • 33
    Kerkvliet EH, Jansen ID, Schoenmaker TA, Docherty AJ, Beertsen W, Everts V 2003 Low molecular weight inhibitors of matrix metalloproteinases can enhance the expression of matrix metalloproteinase-2 (gelatinase A) without inhibiting its activation. Cancer 97: 15821588.
  • 34
    Creemers LB, Jansen ID, Docherty AJ, Reynolds JJ, Beertsen W, Everts V 1998 Gelatinase A (MMP-2) and cysteine proteinases are essential for the degradation of collagen in soft connective tissue. Matrix Biol 17: 3546.
  • 35
    Roth W, Deussing J, Botchkarev VA, Pauly-Evers M, Saftig P, Hafner A, Schmidt P, Schmahl W, Scherer J, Anton-Lamprecht I, Von Figura K, Paus R, Peters C 2000 Cathepsin L deficiency as molecular defect of furless: Hyperproliferation of keratinocytes and perturbation of hair follicle cycling. FASEB J 14: 20752086.
  • 36
    Halangk W, Lerch MM, Brandt-Nedelev B, Roth W, Ruthenbuerger M, Reinheckel T, Domschke W, Lippert H, Peters C, Deussing J 2000 Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 106: 773781.
  • 37
    Buttle DJ, Murata M, Knight CG, Barrett AJ 1992 CA074 methyl ester: A proinhibitor for intracellular cathepsin B. Arch Biochem Biophys 299: 377380.
  • 38
    Everts V, Delaisse JM, Korper W, Jansen DC, Tigchelaar-Gutter W, Saftig P, Beertsen W 2002 The bone lining cell: Its role in cleaning Howship's lacunae and initiating bone formation. J Bone Miner Res 17: 7790.
  • 39
    Kiviranta R, Morko J, Alatalo SL, Nicamhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E 2005 Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio. Bone 36: 159172.
  • 40
    Okaji M, Sakai H, Sakai E, Shibata M, Hashimoto F, Kobayashi Y, Yoshida N, Okamoto K, Yamamoto K, Kato Y 2003 The regulation of bone resorption in tooth formation and eruption processes in mouse alveolar crest devoid of cathepsin K. J Pharmacol Sci 91: 285294.
  • 41
    Potts W, Bowyer J, Jones H, Tucker D, Freemont AJ, Millest A, Martin C, Vernon W, Neerunjun D, Slynn G, Harper F, Maciewicz R 2004 Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy. Int J Exp Pathol 85: 8596.
  • 42
    Everts V, Hou WS, Rialland X, Tigchelaar W, Saftig P, Bromme D, Gelb BD, Beertsen W 2003 Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts. Calcif Tissue Int 73: 380386.
  • 43
    Aibe K, Yazawa H, Abe K, Teramura K, Kumegawa M, Kawashima H, Honda K 1996 Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits. Biol Pharm Bull 19: 10261031.
  • 44
    Henriksen K, Sorensen MG, Nielsen RH, Gram J, Schaller S, Dziegiel MH, Everts V, Bollerslev J, Karsdal MA 2006 Degradation of the organic phase of bone by osteoclasts: A secondary role for lysosomal acidification. J Bone Miner Res 21: 5866.
  • 45
    James IE, Marquis RW, Blake SM, Hwang SM, Gress CJ, Ru Y, Zembryki D, Yamashita DS, McQueney MS, Tomaszek TA, Oh HJ, Gowen M, Veber DF, Lark MW 2001 Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro. J Biol Chem 276: 1150711511.
  • 46
    Murphy G, Ward R, Gavrilovic J, Atkinson S 1992 Physiological mechanisms for metalloproteinase activation. Matrix Suppl 1: 224230.